News | Computed Tomography (CT) | August 08, 2016

Findings of ultra-low cost study reveal more differences in CT lung cancer screening protocols than expected, highlighting need for better communication, education and resources

CT lung cancer screening, computed tomography, crowd-sourced study, image quality, Prevent Cancer Foundation workshop

August 8, 2016 — An overview of the initial findings and results from the CT Lung Screening Protocol Challenge was announced at the Prevent Cancer Foundation Quantitative Imaging Workshop on June 13, 2016.

This first-of-its-kind study allowed researchers to evaluate the protocols and image quality performance of currently-deployed computed tomography (CT) scanners for low-dose CT lung cancer screening. The researchers also obtained initial data on the applicability of these scanners and protocols for chronic obstructive pulmonary disease (COPD). The use of 3M Scotch Magic tape as an image quality reference object provided an ultra-low cost and novel method of evaluating fundamental CT image quality performance across a scanner’s field of view. 3M Scotch tape is manufactured so that this product’s dimensions are extremely consistent.

Over a two-month data collection period, the information received from CT lung cancer screening image data was automatically analyzed. Data were received from 26 healthcare institutions, 53 CT scanners and approximately 128 individual CT scans. Preliminary analysis of the study data revealed larger differences in CT scanning protocols than expected, despite low-dose lung cancer screening recommendations and guidelines from major societies. These data highlighted the need for more communication, education and resources for establishing and verifying CT imaging protocols.

The study data also revealed a critical need to continue collecting large databases of image quality data and also revealed many opportunities to improve CT scanners and imaging methods to better support detection and quantitative measurement of early lung disease.

The Challenge data review committee is now preparing a manuscript of the preliminary Challenge findings, which will be submitted for review in August.

For more information: www.preventcancer.org


Related Content

News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Lung Imaging

March 11, 2026 — Noah Medical has announced the publication of the MATCH 2 study in the international, peer-reviewed ...

Time March 12, 2026
arrow
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | Computed Tomography (CT)

March 5, 2026 — At ECR 2026, Royal Philips introduced Rembra, its next-generation radiology CT system designed for the ...

Time March 09, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Imaging

March 2, 2026 — Esaote Group will officially launch the new MyLab E85 and MyLab C30 GTS Edition ultrasound systems at ...

Time March 02, 2026
arrow
Subscribe Now